FDC
Back to Balance Sheet
|
FDC Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹31 Cr | ₹23 Cr | ₹17 Cr | ₹11 Cr | ₹16 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of FDC ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹31 Cr |
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹16 Cr |
How is Deferred Tax Assets / Liabilities of FDC Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹31 Cr | 34.14 | |
| Mar2025 | ₹23 Cr | 32.90 | |
| Mar2024 | ₹17 Cr | 55.45 | |
| Mar2023 | ₹11 Cr | -31.06 | |
| Mar2022 | ₹16 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,462.8 Cr | -1.6% | 0.1% | -26.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -1.6% |
0.1% |
-26.9% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses